Assess whether related-party sales should be backed out of valuation (f590a7)

SITUATION In a cross-border deal with earnout-heavy structure, management-team retention and key-person map is the evidence after add-backs that are just delayed opex. Commercial-diligence partner has to pick Proceed or Reprice for this M&A Due Diligence Legal, IP, and Regulatory close using management-team retention and key-person map.

DECISION Commercial-diligence partner in a cross-border deal with earnout-heavy structure must choose Proceed / Reprice / Walk / Hold using management-team retention and key-person map after add-backs that are just delayed opex.

HYPOTHESES TO TEST 1. Commercial-diligence partner can defend Proceed from management-team retention and key-person map after add-backs that are just delayed opex in a M&A Due Diligence challenge. 2. Commercial-diligence partner cannot defend Proceed from management-team retention and key-person map; Reprice is what the extract actually supports after add-backs that are just delayed opex. 3. Add-backs that are just delayed opex never reached the population in management-team retention and key-person map — reopen intake, do not close related-party sales should be. 4. Two facts in management-team retention and key-person map after add-backs that are just delayed opex conflict for commercial-diligence partner; hold this Legal, IP, and Regulatory file.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in management-team retention and key-person map. 2. Map reps, earnout mechanics, and integration risk a cross-border deal with earnout-heavy structure would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in management-team retention and key-person map to related-party sales should be. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read management-team retention and key-person map against add-backs that are just delayed opex and write the one fact that would move related-party sales should be for commercial-diligence partner.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (management-team retention and key-person map after add-backs that are just delayed opex). If management-team retention and key-person map cannot force a M&A Due Diligence label under Legal, IP, and Regulatory, stop. If management-team retention and key-person map after add-backs that are just delayed opex cannot support Proceed versus Reprice on this M&A Due Diligence Legal, IP, and Regulatory close, commercial-diligence partner must do not proceed, reprice, or walk on a quality-of-earnings fact the packet does not carry.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on related-party sales should be, then the evidence in management-team retention and key-person map, then the action for commercial-diligence partner - Hypothesis scorecard against management-team retention and key-person map: supported / rejected / untestable - Owner and next date for commercial-diligence partner in a cross-border deal with earnout-heavy structure - What changes related-party sales should be if add-backs that are just delayed opex is later withdrawn